Back to top
more

Enzymotec Ltd. (ENZY)

(Real Time Quote from BATS)

$11.85 USD

11.85
NA

-0.03 (-0.21%)

Updated Jan 10, 2018 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

[ENZY]

Reports for Purchase

Showing records 1 - 16 ( 16 total )

Industry: Medical - Products

Record: 1

04/08/2015

Company Report

Pages: 4

Dropping Coverage

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 2

08/05/2014

Company Report

Pages: 9

Q2 Miss and Lowered 2014 Guidance, Recovery Likely to Take Longer; Maintain OUTPERFORM, Lowering PT to $14

Provider: WEDBUSH SECURITIES INC.

Analyst: DIONISIO R

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 3

07/16/2014

Daily Note

Pages: 26

Q2 Consumer Sector Preview: PII Appears Most Likely to Beat/Raise

Provider: WEDBUSH SECURITIES INC.

Analyst: DIONISIO R

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 4

05/14/2014

Company Report

Pages: 9

Lowered 2014 Guidance, but Primarily on Temporary Challenges; Maintain OUTPERFORM, Lowering PT to $25

Provider: WEDBUSH SECURITIES INC.

Analyst: DIONISIO R

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 5

04/16/2014

Daily Note

Pages: 24

Q1 Consumer Sector Preview

Provider: WEDBUSH SECURITIES INC.

Analyst: DIONISIO R

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 6

04/16/2014

Daily Note

Pages: 24

Q1 Consumer Sector Preview: HLF Most Likely to Beat/Raise, but HOG and ELY Face Near-Term Challenges

Provider: WEDBUSH SECURITIES INC.

Analyst: DIONISIO R

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 7

02/19/2014

Company Report

Pages: 9

Delivers Another Solid Quarter of Earnings Upside Since Going Public; Maintain OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: DIONISIO R

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 8

01/21/2014

Daily Note

Pages: 24

Q4 Consumer Sector Preview

Provider: WEDBUSH SECURITIES INC.

Analyst: DIONISIO R

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 9

01/21/2014

Daily Note

Pages: 24

Q4 Consumer Sector Preview: Snowmobile Manufacturers Most Likely to Benefit from Recent Weather Conditions

Provider: WEDBUSH SECURITIES INC.

Analyst: DIONISIO R

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 10

01/13/2014

Company Report

Pages: 8

Solid Progress on Capacity Expansion Initiatives; Maintain OUTPERFORM and PT of $33.

Provider: WEDBUSH SECURITIES INC.

Analyst: DIONISIO R

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 11

12/11/2013

Industry Report

Pages: 11

Key Takeaways from the Conference

Provider: WEDBUSH SECURITIES INC.

Analyst: DIONISIO R

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 12

12/10/2013

Industry Report

Pages: 11

RETAIL AND CONSUMER

Provider: WEDBUSH SECURITIES INC.

Analyst: DIONISIO R

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 13

11/11/2013

Company Report

Pages: 9

Solid Q3 EPS Upside in First Quarter of Being Public;

Provider: WEDBUSH SECURITIES INC.

Analyst: DIONISIO R

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 14

10/28/2013

Industry Report

Pages: 5

Upcoming Potential Catalysts, Significant Events and Research Review Week of October 28 - November 1

Provider: WEDBUSH SECURITIES INC.

Analyst: DIONISIO R

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 15

10/28/2013

Industry Report

Pages: 5

Upcoming Potential Catalysts, Significant Events and Research Review Week of October 28 - November 1

Provider: WEDBUSH SECURITIES INC.

Analyst: DIONISIO R

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Products

Record: 16

10/22/2013

Company Report

Pages: 19

Initiating Coverage with OUTPERFORM Rating and $21 PT: Expect Increased Share in Rapidly Growing End Markets

Provider: WEDBUSH SECURITIES INC.

Analyst: DIONISIO R

Price: 50.00

Research Provided by a Third Party
// eof